{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15592997",
  "DateCompleted": {
    "Year": "2005",
    "Month": "01",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2015",
    "Month": "11",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2004",
        "Month": "12",
        "Day": "01"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0022-1899",
      "JournalIssue": {
        "Volume": "191",
        "Issue": "1",
        "PubDate": {
          "Year": "2005",
          "Month": "Jan",
          "Day": "01"
        }
      },
      "Title": "The Journal of infectious diseases",
      "ISOAbbreviation": "J Infect Dis"
    },
    "ArticleTitle": "Etiologies and manifestations of persistent diarrhea in adults with HIV-1 infection: a case-control study in Lima, Peru.",
    "Pagination": {
      "StartPage": "11",
      "EndPage": "19",
      "MedlinePgn": "11-9"
    },
    "Abstract": {
      "AbstractText": [
        "OBJECTIVE We sought to determine the etiologies, manifestations, and risk factors for persistent (> or =7 days) diarrhea in human immunodeficiency virus type 1 (HIV-1)-infected persons in Peru.",
        "The present study is a case-control study of 147 HIV-1-infected case subjects with persistent diarrhea and 147 HIV-1-infected control subjects without diarrhea.",
        "We obtained clinical, demographic, and exposure data, CD4 lymphocyte counts, and stool samples for detection of enteric parasitic and bacterial pathogens and rotavirus.",
        "One or more enteric pathogen was identified in 55% of case subjects and 21% of control subjects (odds ratio adjusted for CD4 lymphocyte count, 3.8; 95% confidence interval, 2.2-6.5). The median CD4 lymphocyte count was highest with pathogen-free diarrhea and lowest with Cryptosporidium infection. Cryptosporidium species (the most frequent pathogen), Giardia lamblia, Aeromonas species, Campylobacter species, and rotavirus were all significantly associated with diarrhea. Bacterial pathogens were significantly associated with G. lamblia and rotavirus infection. Of the bacterial pathogens (Aeromonas, Campylobacter, Salmonella, and Vibrio species and enterotoxigenic Escherichia coli), only 24% were susceptible to cotrimoxazole, whereas 90% were susceptible to ciprofloxacin. In no case did the sensitivity or positive predictive value of specific clinical and laboratory findings for curable enteric infections exceed 50%.",
        "Several enteric pathogens were associated with diarrhea in HIV-1-infected case subjects in Peru, especially among those who were heterosexual. Clinical findings were poor predictors of detectable microbial etiology. The guidelines for initial management of chronic diarrhea with sulfamethoxazole-trimethoprim in HIV-1-infected persons require revision, at least in settings where prophylaxis with this agent is common."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departments of Epidemiology, University of Washington, Seattle, Washington 98140, USA."
          }
        ],
        "LastName": "C\u00e1rcamo",
        "ForeName": "C\u00e9sar",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Hooton",
        "ForeName": "Thomas",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wener",
        "ForeName": "Mark H",
        "Initials": "MH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Weiss",
        "ForeName": "Noel S",
        "Initials": "NS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gilman",
        "ForeName": "Robert",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Arevalo",
        "ForeName": "Jorge",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Carrasco",
        "ForeName": "Juan",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Seas",
        "ForeName": "Carlos",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Caballero",
        "ForeName": "Martin",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Holmes",
        "ForeName": "King K",
        "Initials": "KK"
      }
    ],
    "GrantList": [
      {
        "GrantID": "D43 TW00007-06",
        "Acronym": "TW",
        "Agency": "FIC NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Infect Dis",
    "NlmUniqueID": "0413675",
    "ISSNLinking": "0022-1899"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "5E8K9I0O4U",
      "NameOfSubstance": "Ciprofloxacin"
    },
    {
      "RegistryNumber": "8064-90-2",
      "NameOfSubstance": "Trimethoprim, Sulfamethoxazole Drug Combination"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "drug effects",
        "isolation & purification"
      ],
      "DescriptorName": "Aeromonas"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Bacterial Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "CD4 Lymphocyte Count"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Campylobacter"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Case-Control Studies"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Ciprofloxacin"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Cryptosporidium"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "microbiology",
        "parasitology"
      ],
      "DescriptorName": "Diarrhea"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Escherichia coli"
    },
    {
      "QualifierName": [
        "microbiology",
        "parasitology",
        "virology"
      ],
      "DescriptorName": "Feces"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Giardia lamblia"
    },
    {
      "QualifierName": [
        "complications"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Peru"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "parasitology"
      ],
      "DescriptorName": "Protozoan Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "Rotavirus"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Rotavirus Infections"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Salmonella"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Trimethoprim, Sulfamethoxazole Drug Combination"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Vibrio"
    }
  ]
}